Skip to main content
Erschienen in: International Urogynecology Journal 10/2018

24.02.2018 | Original Article

Evaluation of intra-individual test–re-test variability of uroflowmetry in healthy women and women suffering from stress, urge, and mixed urinary incontinence

verfasst von: Libor Lunacek, Marcel Gärtner, Jan Krhut, David Mika, Radek Sykora, Peter Zvara

Erschienen in: International Urogynecology Journal | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The objective was to evaluate the intra-individual variability of uroflowmetry (UFM) in healthy control subjects and women suffering from stress, urge, and mixed urinary incontinence.

Methods

A total of 35 healthy controls (group A) and 105 women suffering from urinary incontinence were enrolled in the study. Thirty-five women suffered from stress urinary incontinence (group B), 35 women suffered from mixed urinary incontinence (group C), and 35 women with overactive bladder both dry and wet (group D). All participants were asked to perform UFM measurement three times. The following parameters were analyzed: voided volume (VV), peak flow (Qmax), average flow (Qave), volume-corrected peak flow cQmax (cQmax = Qmax/2√ VV), volume-corrected average flow (cQave = Qave/2√ VV), and postvoid residual volume (PVR).
Statistical analysis was performed using the analysis of variance on repeated measurements. Relative error was calculated using variation coefficients reported as a percentage of the average. All descriptive characteristics were reported as means ± standard deviation (SD). p values ≤0.05 were considered statistically significant.

Results

No statistically significant intra-individual difference in any of the recorded parameters was identified among the three UFM recordings in groups A, C, and D. The intra-individual variability of the following parameters reached statistical significance in patients suffering from stress urinary incontinence (group B): Qmax (p = 0.0016), Qave (p = 0.0005), and cQave (p = 0.0389). A significant difference was only observed in comparison between the first and second consecutive recordings.

Conclusions

This study provides evidence supporting the high yield and good intra-individual reproducibility of UFM.
Literatur
1.
Zurück zum Zitat Peter WP, Drake WM Jr. Uroflowmetric observation in gynaecologic patients. JAMA. 1958;166:721–4.CrossRef Peter WP, Drake WM Jr. Uroflowmetric observation in gynaecologic patients. JAMA. 1958;166:721–4.CrossRef
2.
Zurück zum Zitat Fantl JA, Smith PJ, Schneider V, et al. Fluid weight uroflowmetry in women. Am J Obstet Gynecol. 1983;145(8):1017–24.CrossRef Fantl JA, Smith PJ, Schneider V, et al. Fluid weight uroflowmetry in women. Am J Obstet Gynecol. 1983;145(8):1017–24.CrossRef
3.
Zurück zum Zitat Haylen BT, Yang V, Logan V. Uroflowmetry: its current clinical utility for women. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(7):899–903.CrossRef Haylen BT, Yang V, Logan V. Uroflowmetry: its current clinical utility for women. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(7):899–903.CrossRef
4.
Zurück zum Zitat Haylen BT, Ashby D, Sutherst JR, et al. Maximum and average urine flow rates in normal male and female populations—the Liverpool nomograms. Br J Urol. 1989;64:30–8.CrossRef Haylen BT, Ashby D, Sutherst JR, et al. Maximum and average urine flow rates in normal male and female populations—the Liverpool nomograms. Br J Urol. 1989;64:30–8.CrossRef
5.
Zurück zum Zitat Barapatre Y, Agarwal MM, Singh SK, et al. Uroflowmetry in healthy women: development and validation of flow-volume and corrected flow-age nomograms. Neurourol Urodyn. 2009;28:1003–9.CrossRef Barapatre Y, Agarwal MM, Singh SK, et al. Uroflowmetry in healthy women: development and validation of flow-volume and corrected flow-age nomograms. Neurourol Urodyn. 2009;28:1003–9.CrossRef
6.
Zurück zum Zitat Feneley MR, Dunsmuir WD, Pearce J, Kirby RS. Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia. Urology. 1996;47:658–63.CrossRef Feneley MR, Dunsmuir WD, Pearce J, Kirby RS. Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia. Urology. 1996;47:658–63.CrossRef
7.
Zurück zum Zitat Schäfer W, Abrams P, Liao L, et al. International continence society. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002;21:261–74.CrossRef Schäfer W, Abrams P, Liao L, et al. International continence society. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002;21:261–74.CrossRef
9.
Zurück zum Zitat Al Afraa T, Mahfouz W, Campeau L, et al. Normal lower urinary tract assessment in women. I. Uroflowmetry and post-void residual, pad tests, and bladder diaries. Int Urogynecol J. 2012;23:681–5.CrossRef Al Afraa T, Mahfouz W, Campeau L, et al. Normal lower urinary tract assessment in women. I. Uroflowmetry and post-void residual, pad tests, and bladder diaries. Int Urogynecol J. 2012;23:681–5.CrossRef
10.
Zurück zum Zitat Carr LK, Webster GD. Bladder outlet obstruction in women. Urol Clin N Am. 1996;23(3):385–91.CrossRef Carr LK, Webster GD. Bladder outlet obstruction in women. Urol Clin N Am. 1996;23(3):385–91.CrossRef
11.
Zurück zum Zitat Onal B, Silva A, Buldu I, et al. Voiding dysfunction due to multiple sclerosis: a large scale retrospective analysis. Int Brazil J Urol. 2009;35:326–33.CrossRef Onal B, Silva A, Buldu I, et al. Voiding dysfunction due to multiple sclerosis: a large scale retrospective analysis. Int Brazil J Urol. 2009;35:326–33.CrossRef
12.
Zurück zum Zitat Erekson EA, Sung VW, DiSilvestro PA, Myers DL. Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:159–63.CrossRef Erekson EA, Sung VW, DiSilvestro PA, Myers DL. Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:159–63.CrossRef
13.
Zurück zum Zitat Wang KH, Neimark M, Davila GW. Voiding dysfunction following TVT procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13:353–7.CrossRef Wang KH, Neimark M, Davila GW. Voiding dysfunction following TVT procedure. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13:353–7.CrossRef
14.
Zurück zum Zitat Steinberg BJ, Finamore PS, Sastry DN, et al. Postoperative urinary retention following vaginal mesh procedures for the treatment of pelvic organ prolapse. Int Urogynecol J. 2010;21:1491–8.CrossRef Steinberg BJ, Finamore PS, Sastry DN, et al. Postoperative urinary retention following vaginal mesh procedures for the treatment of pelvic organ prolapse. Int Urogynecol J. 2010;21:1491–8.CrossRef
15.
Zurück zum Zitat Rusavy Z, Rivaux G, Fatton B, Cayrac M, Boileau L, de Tayrac R. Voiding difficulties after vaginal mesh cystocele repair: does the perivesical dissection matter? Int Urogynecol J. 2013;24:1385–90.CrossRef Rusavy Z, Rivaux G, Fatton B, Cayrac M, Boileau L, de Tayrac R. Voiding difficulties after vaginal mesh cystocele repair: does the perivesical dissection matter? Int Urogynecol J. 2013;24:1385–90.CrossRef
16.
Zurück zum Zitat Bergman A, Bhatia NN. Uroflowmetry for predicting postoperative voiding difficulties in women with stress urinary incontinence. Br J Obstet Gynaecol. 1985;92(8):835–8.CrossRef Bergman A, Bhatia NN. Uroflowmetry for predicting postoperative voiding difficulties in women with stress urinary incontinence. Br J Obstet Gynaecol. 1985;92(8):835–8.CrossRef
17.
Zurück zum Zitat Hong B, Park S, Kim HS, Choo MS. Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence. J Urol. 2003;170(3):852–6.CrossRef Hong B, Park S, Kim HS, Choo MS. Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence. J Urol. 2003;170(3):852–6.CrossRef
18.
Zurück zum Zitat Ahmed S, McNanley A, Perevich M, Glantz JC, Buchsbaum G. Uroflow measurements in healthy female volunteers. Female Pelvic Med Reconstr Surg. 2010;16(6):327–30.CrossRef Ahmed S, McNanley A, Perevich M, Glantz JC, Buchsbaum G. Uroflow measurements in healthy female volunteers. Female Pelvic Med Reconstr Surg. 2010;16(6):327–30.CrossRef
19.
Zurück zum Zitat Gupta NP, Kumar A, Kumar R. Does position affect uroflowmetry parameters in women? Urol Int. 2008;80:37–40.CrossRef Gupta NP, Kumar A, Kumar R. Does position affect uroflowmetry parameters in women? Urol Int. 2008;80:37–40.CrossRef
20.
Zurück zum Zitat Chou TP, Gorton E, Stanton SL, et al. Can uroflowmetry patterns in women be reliably interpreted? Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:142–7.CrossRef Chou TP, Gorton E, Stanton SL, et al. Can uroflowmetry patterns in women be reliably interpreted? Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:142–7.CrossRef
21.
Zurück zum Zitat Gehrich A, Stany MP, Fischer JR, Buller J, Zahn CM. Establishing a mean postvoid residual volume in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol. 2007;110:827–329.CrossRef Gehrich A, Stany MP, Fischer JR, Buller J, Zahn CM. Establishing a mean postvoid residual volume in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol. 2007;110:827–329.CrossRef
22.
Zurück zum Zitat Griffiths CJ, Murray A, Ramsden PD. Accuracy and repeatability of bladder volume measurement using ultrasonic imaging. J Urol. 1986;136(4):808–12.CrossRef Griffiths CJ, Murray A, Ramsden PD. Accuracy and repeatability of bladder volume measurement using ultrasonic imaging. J Urol. 1986;136(4):808–12.CrossRef
23.
Zurück zum Zitat Costantini E, Mearini E, Pajoncini C, Biscotto S, Bini V, Porena M. Uroflowmetry in female voiding disturbances. Neurourol Urodyn. 2003;22(6):569–73.CrossRef Costantini E, Mearini E, Pajoncini C, Biscotto S, Bini V, Porena M. Uroflowmetry in female voiding disturbances. Neurourol Urodyn. 2003;22(6):569–73.CrossRef
Metadaten
Titel
Evaluation of intra-individual test–re-test variability of uroflowmetry in healthy women and women suffering from stress, urge, and mixed urinary incontinence
verfasst von
Libor Lunacek
Marcel Gärtner
Jan Krhut
David Mika
Radek Sykora
Peter Zvara
Publikationsdatum
24.02.2018
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 10/2018
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3571-0

Weitere Artikel der Ausgabe 10/2018

International Urogynecology Journal 10/2018 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.